David A Reardon, MD
Dana-Farber Cancer Institute
3
3
2
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jiayi Huang, M.D.
Washington University School of Medicine
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Thomas Kaley, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Daniel Landi, MD
Duke University
Shared therapeutic areas:
Alina Markova, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Christian Grommes, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Jeffrey Skolnik, MD
Inovio Pharmaceuticals
Shared therapeutic areas:
Francois Benard, MD
BC Cancer
Shared therapeutic areas:
Jane Robertson
AstraZeneca
Shared therapeutic areas:
Jeffrey Raizer, MD
Northwestern University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
ASP8374 + Cemiplimab in Recurrent Glioma
Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma
All 3 trials loaded